PLACENTA-MEDIATED PREGNANCY COMPLICATIONS: MOLECULAR MARKERS AND CONTEMPORARY APPROACHES TO CLINICAL PREVENTION

Placenta-mediated pregnancy complications, including preeclampsia, fetal growth restriction, preterm birth, and other disorders of perinatal development, remain a major challenge in modern obstetrics. Their development is associated with complex pathophysiological processes, among which impaired placental formation, angiogenesis, endothelial function, and uteroplacental blood flow play a key role. Particular attention is paid to homocysteine as a potential contributor to vascular dysfunction and impaired placentation. Elevated homocysteine levels may be accompanied by oxidative stress, endothelial dysfunction, and alterations in spiral artery remodeling, thereby creating conditions that predispose to placental dysfunction. The aim of this study is to summarize current evidence on the significance of molecular and biochemical markers in predicting placenta-mediated pregnancy complications and to analyze evidence-based approaches to their prevention. The roles of pregnancy-associated plasma protein A (PAPP-A), alpha-fetoprotein (AFP), the β-subunit of human chorionic gonadotropin (β-hCG), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and the sFlt-1/PlGF ratio are examined. These markers reflect different aspects of placental function and angiogenic balance; however, their predictive value depends on gestational age, clinical context, and their combination with other risk factors. Contemporary approaches to the prevention of preeclampsia and other placenta-mediated complications are also analyzed, particularly the use of acetylsalicylic acid and low-molecular-weight heparins. It is emphasized that preventive therapy should be based on individualized risk assessment and current evidence-based recommendations, since the effectiveness of certain interventions -especially low-molecular-weight heparins in the absence of specific indications -remains a subject of scientific debate. The findings suggest that a comprehensive approach to prediction, combining medical history and clinical characteristics with laboratory and angiogenic markers, holds promise. Such a strategy may facilitate the early identification of pregnant women at increased risk and the timely implementation of preventive measures.

Authors

Institutions

Publication Details

Journal
Middle European Scientific Bulletin
Published
2026-11-13
DOI
https://doi.org/10.65237/2336-3630-2026-11(1)-11
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PLACENTA-MEDIATED PREGNANCY COMPLICATIONS: MOLECULAR MARKERS AND CONTEMPORARY APPROACHES TO CLINICAL PREVENTION

Печеряга Світлана Володимирівна, Ivanna Olivinska
Middle European Scientific Bulletin
Pregnancy and preeclampsia studies
article

PLACENTA-MEDIATED PREGNANCY COMPLICATIONS: MOLECULAR MARKERS AND CONTEMPORARY APPROACHES TO CLINICAL PREVENTION

Печеряга Світлана Володимирівна, Ivanna Olivinska
article en

Abstract

Placenta-mediated pregnancy complications, including preeclampsia, fetal growth restriction, preterm birth, and other disorders of perinatal development, remain a major challenge in modern obstetrics. Their development is associated with complex pathophysiological processes, among which impaired placental formation, angiogenesis, endothelial function, and uteroplacental blood flow play a key role. Particular attention is paid to homocysteine as a potential contributor to vascular dysfunction and impaired placentation. Elevated homocysteine levels may be accompanied by oxidative stress, endothelial dysfunction, and alterations in spiral artery remodeling, thereby creating conditions that predispose to placental dysfunction. The aim of this study is to summarize current evidence on the significance of molecular and biochemical markers in predicting placenta-mediated pregnancy complications and to analyze evidence-based approaches to their prevention. The roles of pregnancy-associated plasma protein A (PAPP-A), alpha-fetoprotein (AFP), the β-subunit of human chorionic gonadotropin (β-hCG), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and the sFlt-1/PlGF ratio are examined. These markers reflect different aspects of placental function and angiogenic balance; however, their predictive value depends on gestational age, clinical context, and their combination with other risk factors. Contemporary approaches to the prevention of preeclampsia and other placenta-mediated complications are also analyzed, particularly the use of acetylsalicylic acid and low-molecular-weight heparins. It is emphasized that preventive therapy should be based on individualized risk assessment and current evidence-based recommendations, since the effectiveness of certain interventions -especially low-molecular-weight heparins in the absence of specific indications -remains a subject of scientific debate. The findings suggest that a comprehensive approach to prediction, combining medical history and clinical characteristics with laboratory and angiogenic markers, holds promise. Such a strategy may facilitate the early identification of pregnant women at increased risk and the timely implementation of preventive measures.

Middle European Scientific BulletinVol. 1(11)
Bukovinian State Medical University (UA)
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon